Quetiapine Tablet, Film Coated, Extended Release
Product Images NDC 69948-002

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 69948-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alignscience Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7366858f 2734 4214 A5ba 66307182fd62 150mg500s

Quetiapine Extended-Release Tablets, USP 150 mg oral extended-release film-coated tablets. The label states the strength as 150 mg and dosage as once daily. It includes manufacturer information for AlignScience Pharma Inc. and Haimen Pharma Inc. The package contains 500 tablets and has storage and usage warnings visible.*

FDA Label Image

7366858f 2734 4214 A5ba 66307182fd62 150mg60s

Label for Quetiapine Extended-Release Tablets, USP 150 mg, film-coated extended-release oral tablets. The label includes dosing instruction 'Once Daily,' a 60 tablet count, and states the product is for prescription use only. Manufactured for AlignScience Pharma Inc. and by Haimen Pharma Inc. in China. The label also advises to dispense the Medication Guide to patients and includes storage conditions, warnings, and NDC 69948-002-03.*

FDA Label Image

7366858f 2734 4214 A5ba 66307182fd62 200mg500s

Label for Quetiapine Extended-Release Tablets, USP 200 mg, once daily oral tablets. The package contains 500 film-coated extended-release tablets. Labeler is AlignScience Pharma Inc. The label includes dosage instructions to swallow whole and storage conditions. Manufacturer information in China is also provided.*

FDA Label Image

7366858f 2734 4214 A5ba 66307182fd62 200mg60s

Label for Quetiapine Extended-Release Tablets, USP 200 mg, oral tablet film coated extended release by AlignScience Pharma Inc. The label shows 60 tablets in the package, instructions to swallow whole without crushing or chewing, and storage information. It includes an NDC barcode and advises dispensing the Medication Guide to patients.*

FDA Label Image

7366858f 2734 4214 A5ba 66307182fd62 Chemical Structure

Chemical structure diagram showing the molecular structure of quetiapine and an associated ion, representing the active ingredient quetiapine in the extended-release tablet form by AlignScience Pharma Inc.*

FDA Label Image

7366858f 2734 4214 A5ba 66307182fd62 Figure 1

A line graph depicting the proportion of patients with relapse (%) over time (months) for two groups: PLA (placebo) and QTP XR (Quetiapine Extended-Release). The vertical axis shows relapse percentages from 0 to 100%, and the horizontal axis tracks time from 0 to 7 months. The PLA group's relapse proportion increases more steeply than the QTP XR group over the observation period.*

FDA Label Image

7366858f 2734 4214 A5ba 66307182fd62 Figure 2

A line graph showing the proportion of patients with relapse (%) over time in weeks. Two groups are compared: QTP+ LI/VAL (dashed line) and PLA+ LI/VAL (solid line). The proportion of relapse increases more rapidly in the PLA+ LI/VAL group than in the QTP+ LI/VAL group over a 100-week period.*

FDA Label Image

7366858f 2734 4214 A5ba 66307182fd62 Figure 3

A line graph illustrating the proportion of patients with relapse (%) over time in weeks, comparing two groups: QTP + LIVAL, shown with a dashed line, and PLA + LIVAL, shown with a solid line. The graph shows relapse percentages increasing over an 80-week period, with the PLA + LIVAL group having a higher proportion of relapse.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.